ESG

ESG Talks Season 2

To begin the second season of ESG Talk, host Mandi McReynolds delves into the year’s theme—perspective and the diversity of thought shaping ESG. A new perspective, according to Mandi, can …

Keys to sustainable future through AI

Digital twins aren’t new, but AI is expanding their capabilities. They are changing the way products are designed, manufactured, and maintained. The technology combination provides forensic insights into our increasingly …

Novartis boosts value chain for stakeholders, embeds ESG in core business operations

By embedding environmental, social and governance (ESG) topics into core business strategy and operations, Novartis aims to build trust with society and deliver long-term value to stakeholders. In February, the company released its first Novartis in Society Integrated Report 2021, marking a new approach to reporting which describes how it creates value for stakeholders through its purpose of reimagine medicine to improve and extend people’s lives. As a case in point, in 2021, Novartis’ medicines reached 766 million patients pf which 56.2 patients were reached through its various access-to-medicine approaches. This report is intended for all Novartis stakeholders, and it complies with specific requirements of investors and ESG professionals.